Hypertension is a ubiquitous problem that many companies – both pharma and device – are looking to address. Now, a privately held Mountain View, Calif.-based company, Vascular Dynamics Inc., is looking to offer a new minimally invasive option that can help patients who are resistant to drug therapies.